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Jaundice may be present at the time of birth or may appear at any time during the neonatal period, depending on etiology [1]. Jaundice usually becomes apparent in a cephalocaudal 
progression, starting on the face and progressing to the abdomen 
and then the feet, as serum levels increase [2]. Hyperbilirubinemia 
in infants ≥35 weeks gestation is defined as total bilirubin 
>95th percentile on the hour-specific Bhutani normogram [3]. 
Term “acute bilirubin encephalopathy” describes the acute clinical 
manifestations of bilirubin-induced neurological dysfunction [4]. 
Appropriate intervention is important to consider in every infant 
with severe hyperbilirubinemia [4]. Phototherapy and, if it is 
unsuccessful, exchange transfusion remain the primary treatment 
modality to keep the maximal total serum bilirubin below 
pathologic levels [5]. Infants under phototherapy have long been 
proposed to be at risk for developing hypocalcemia, especially 
preterm newborn [1].
The precise blood level above which indirect-reacting 
bilirubin or free bilirubin will be toxic for an individual infant 
is unpredictable, but in a large series, kernicterus occurred only 
in infants with a bilirubin >20 mg/Dl [6]. 90%percent of the 
infants, in whom kernicterus developed, were previously healthy 
predominantly breastfed term and near-term infants [7]. The 
duration of exposure to high bilirubin levels needed to produce 
toxic effects is unknown [3]. The more immature the infant is, the 
greater is the susceptibility to kernicterus [2]. A number of studies 
are available on this regard in literature, but with conflicting 
results, and moreover, the mechanism for this hypocalcemia is 
also not clearly elucidated till now. However, increased urinary 
calcium excretion is one of the most promising theoretical 
hypothesis till now. Only a few studies have demonstrated 
hypocalcemia in neonates receiving phototherapy; therefore, this 
study was planned to determine the effect of phototherapy on 
ABSTRACT
Introduction: Although hypocalcemia is often proposed to be associated with phototherapy in both term and preterm newborns, 
its exact incidence, clinical significance, and underlying mechanism still remain to be elucidated. Objective: The objective 
of this study was to determine the prevalence of hypocalcemia and its etiopathogenesis in terms of urinary calcium excretion. 
Methods: This study was carried out in a tertiary care center in North India with 50 neonates (29 term and 21 preterm) in the 
test group receiving single surface phototherapy. The other 50 age, sex, and gestational age-matched neonates were taken as 
controls who did not receive phototherapy. Serum calcium levels at 0 and 48 h and urinary calcium/creatinine ratio (mg/mg) at 
0 and 24 h of starting phototherapy were determined in both the groups and compared. Results: Total 12 preterm (57.1%) and 
9 term newborns (31%) developed hypocalcemia after 48 h of phototherapy. The mean difference of serum ionized calcium 
between two groups was statistically significant at 48 h (4.58 mg/dl in the test group vs. 4.94 mg/dl in the control group, 
p<0.001). Percentage change in mean of urinary calcium/creatinine ratio at 24 h from baseline was 1.39% in the control 
group while it was 60.7% in the test group with statistically significant difference (p<0.001) between two groups. Only a 
weak negative correlation between serum ionized calcium and urinary calcium/creatinine ratio with correlation coefficient 
r=−0.316 could be established in the study among both term and preterm neonates. Conclusion: Both preterm and term 
neonates undergoing phototherapy are at increased risk for hypocalcemia and increased urinary calcium excretion. A universal 
recommendation regarding calcium supplementation in neonates undergoing phototherapy is yet to be established but seems 
like a reasonable intervention.
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ionized serum calcium level and ratio of spot urinary calcium and 
urinary creatinine in newborns.
MATERIALS AND METHODS
This observational analytic study was carried out at the neonatal 
intensive care unit of the Department of Paediatrics, of a tertiary 
care hospital, New Delhi, between November 2013 and June 
2015. Prior approval from the institutional ethics committee was 
obtained and neonates were recruited after obtaining informed 
consent from the primary caregiver. The study population 
included all newborns, including male and female, and preterm 
and term, admitted in hospital for phototherapy and observation 
due to hyperbilirubinemia. All those babies who were at known 
risk of developing hypocalcemia such as small for gestation, 
infants of diabetic mothers, exposed to asphyxia, having 
respiratory distress, neonatal sepsis, sodium bicarbonate therapy, 
hemolytic conditions such as Rh incompatibility and glucose-6-
phosphodehydrogenase (G6PD) deficiency, and hypothyroidism 
were excluded from the study.
The participants were divided into test and control group, 
having 50 newborns enrolled in each group. The test group 
included the newborn babies with neonatal hyperbilirubinemia, 
with serum bilirubin levels above the minimum value requiring 
phototherapy; irrespective of the fact whether they also 
required exchange transfusion of blood during the course of 
illness. Phototherapy and exchange transfusion charts given 
by the American Academy of Pediatrics in 2004 for term 
babies and in preterm exchange transfusion level was taken 
by recommendations given by National Neonatology Forum in 
2006 guidelines, were followed. Initially, the newborns were 
started on single surface phototherapy; if the serum bilirubin 
value was not touching the exchange transfusion level. The 
controls included newborns, both term and preterm, who had 
neonatal hyperbilirubinemia, but their level was not high enough 
to need phototherapy. These controls were enrolled in such a 
way to match the test group with respect to age, sex, period of 
gestation, and birth weight. These babies were managed without 
phototherapy.
All enrolled neonates were evaluated with detailed history 
and thorough physical examination. A relevant antenatal, natal, 
postnatal, and family history were inquired and a detailed general 
and systemic examination were performed in each case. Every 
case was investigated for serum ionized calcium, serum bilirubin, 
blood group, and Rh typing, hemoglobin, peripheral blood smear, 
urinary calcium, urinary creatinine, erythrocyte G6PD enzyme 
deficiency, serum thyroid-stimulating hormone, C-reactive 
protein, microerythrocyte sedimentation rate, total leukocyte 
count, absolute neutrophilic count, and immature-to-mature 
neutrophils ratio.
Figure 1: Distribution of cases according to total serum bilirubin (mg/dl) in preterm and term of the control and test group at 48 h of enrolment
Table 1: Mean distribution of serum ionized calcium and urinary calcium/urinary creatinine ratio in the control group between preterm 
and term
Parameters Preterm (n=23) Term (n=27) p value
Mean±SD Min–Max Mean±SD Min–Max
Serum ionized calcium
0 h 4.84±0.20 4.40–5.21 5.04±0.09 4.86–5.20 <0.001*
48 h 4.84±0.23 4.38–5.20 5.03±0.10 4.8–5.24 <0.001*
Ratio
0 h 0.27±0.03 0.23–0.34 0.25±0.02 0.21–0.28 0.009*
24 h 0.27±0.05 0.19–0.40 0.24±0.03 0.20–0.29 0.028*
SD: Standard deviation
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Mothers were also examined for their blood group and Rh 
typing. Serum ionized calcium level was measured at 0 h of 
starting phototherapy and at 48 h for both the groups. Urinary 
calcium/creatinine ratio was determined at 0 h and 24 h for both 
the groups. Normal serum ionized calcium in term neonates was 
taken as 4.8 mg/dl and preterm neonates at 4.0 mg/dl on the basis 
of the available literature. The normal values for spot urinary 
calcium and urinary creatinine ratio were taken on the basis of 
previously done studies, and the spot urinary calcium and urinary 
creatinine ratio ≥0.8 were considered as hypercalciuria.
The required data were recorded in a predesigned case record 
form and later on shifted to Microsoft Excel spreadsheet for 
statistical analysis. Statistical testing was conducted with the 
Statistical Package for the Social Sciences system version SPSS 
17.0. Continuous variables are presented as mean±standard 
deviation, and categorical variables are presented as absolute 
numbers and percentage. The comparison of normally distributed 
continuous variables between the groups was performed using 
Student’s t-test. Nominal categorical data between the groups were 
compared using Chi-squared test. Spearman correlation was also 
used to see the relationship between serum ionized calcium and 
urinary calcium/creatinine ratio at 0 h and 48 h. For all statistical 
tests, p>0.05 was considered as statistically significantly different.
RESULTS
The total number of newborns enrolled in the current study was 
100, of which 50 cases (50%) were included in the test group and 
50 cases (50%) were included in the control group. Distribution 
of cases according to total serum bilirubin in preterm and 
term newborns at 48 h of enrolment is presented in Fig. 1. Of 
the 50 cases, 29 (58%) were term and 21 (42%) were preterm 
and among the 50 controls, 27 (54%) were term and 27 (46%) 
neonates were preterm. In the test group, of 21 preterm newborns, 
12 (57.1%) and of 29 term newborns, 9 (31%) developed 
hypocalcemia after 48 h of phototherapy Table 1. The mean 
difference of serum ionized calcium between the two groups was 
found that statistically significant at 48 h with mean for the test 
group was 4.58 mg/dl compared to 4.94 mg/dl for the control 
group (p < 0.001).
The percentage change in mean serum ionized calcium in the 
test group at 48 h from baseline (0 h) was statistically significant 
with a value of −7.76% (p<0.001). The percentage change in 
mean of urinary calcium/creatinine ratio in the control group at 
24 h from baseline (0 h) was −1.39% while for the test group, 
the value was 60.7%. It was found that there was significant 
difference in percentage change in mean of urinary calcium/
creatinine ratio between the two groups (p<0.001). However, 
only 2 preterm neonates (9.5%) and 2 term neonates (6.9%) had 
significant hypercalciuria after 24 h of phototherapy, according to 
accepted norms in literature; whereas, none of the neonate in the 
control group showed hypercalciuria Tables 2 and 3.
Only a weak negative correlation between serum ionized 
calcium and urinary calcium/creatinine ratio with correlation 
coefficient r=−0.316 could be established in this study 
among both term and preterm neonates; however, it might be 
confounded by small number of newborns with hypercalciuria 
Figs. 1 and 2. There were a total of 10 preterm neonates (47.3%) 
Figure 2: Correlation of urinary calcium/urinary creatinine ratio 
and serum ionized calcium in the control group after 24 h and 48 h 
of enrolment, respectively
Figure 3: Correlation of urinary calcium/urinary creatinineratio 
and serum ionized calcium in the test group after phototherapy
Table 2: Relation between serum ionized calcium and urinary calcium/urinary creatinine ratio among preterm and term of both groups at 
the time of enrolment
Serum ionized calcium at 
0 h (mg/dl)
Urinary calcium/urinary creatinine 
ratio mg/mg
Control group Test group
Preterm (%) Term (%) Preterm (%) Term (%)
≤4.0 for preterm <0.8 0 (0) 0 (0) 0 (0) 0 (0)
≤4.8 for term babies ≥0.8 0 (0) 0 (0) 0 (0) 0 (0)
≥4.0 for preterm <0.8 23 (100) 27 (100) 21 (100) 29 (100)
≥4.8 for term babies ≥0.8 0 (0) 0 (0) 0 (0) 0 (0)
Total 23 27 21 29
Vol 5 | Issue 10 | October 2018 Indian J Child Health 629
Gupta et al. Assessment of phototherapy-induced hypocalcemia and its correlation with 
urinary calcium excretion in newborns with neonatal hyperbilirubinemia
in the test group who showed hypocalcemia, but non-significant 
hypercalciuria and only 2 preterm neonates (9.5%) showed 
hypercalciuria with low serum ionized calcium. Among the nine 
term newborns of the test group, who developed hypocalcemia, 
only 2 preterm neonates (9.5%) showed hypercalciuria with 
remaining 7 preterm neonates (38.1%) of the test group did not 
show hypercalciuria.
DISCUSSION
The current study showed that the incidence of hypocalcemia and 
increased urinary calcium excretion was significantly higher in 
both term and preterm newborns, although there is only weak 
negative correlation between serum calcium level and urinary 
calcium excretion among newborns who received phototherapy. 
Sethi [8] studied 60 neonates with hyperbilirubinemia including 
20 preterm (Group A) and 20 full-term (Group B) neonates 
undergoing phototherapy. 10 neonates from each group formed 
the control group, and they noticed that 90% preterm neonates and 
75% term neonates developed hypocalcemia after phototherapy. 
In this study, 57% preterm and 30% term babies developed 
hypocalcemia after phototherapy which is not consistent with the 
above study results.
They recommended that neonates under phototherapy should 
be supplemented with calcium to prevent hypocalcemia. Jain 
et al. [9] showed similar results in 40 newborn babies with 
hyperbilirubinemia. In their study, the prevalence of phototherapy-
induced hypocalcemia was 55% in preterm infants and 30% in 
full-term neonates. They noticed that 63.6% had jitteriness and 
27.3% had irritability in preterm babies with hypocalcemia. In the 
hypocalcemic full-term neonates, 50% had jitteriness and 16.7% 
had irritability.
They also recommended administration of supplemental 
calcium in phototherapy exposed neonates, to prevent 
hypocalcemia. They have also found the prevalence of 
hypocalcemia to be higher in patients with high level of serum 
bilirubin, although this difference was not statistically significant. 
They concluded that the phototherapy-induced hypocalcemia 
in premature neonates was due to higher penetration of light 
in premature neonates. They also suggested that although 
phototherapy induces hypocalcemia in newborn infants, no 
calcium supplement seems to be required except in symptomatic 
cases. Habibzadeh et al. [10] showed similar results and also 
proposed that hypocalcemia might be due to changes in serum 
Table 3: Relation between serum ionized calcium and urinary calcium/urinary creatinine ratio among preterm and term neonates of both 
groups after 48 and 24 h
Serum ionized calcium at 
0 h (mg/dl)
Urinary calcium/urinary creatinine 
ratio mg/mg
Control group Test group p value
Preterm (%) Term (%) Preterm (%) Term (%)
<4.0 for preterm <0.8 0 (0) 0 (0) 11 (52.3) 9 (31) -
<4.8 for term babies ≥0.8 0 (0) 0 (0) 1 (4.7) 0 (0) -
≥4.0 for preterm <0.8 23 (100) 27 (100) 8 (38.1) 18 (62.6) 0.200
≥4.8 for term babies ≥0.8 0 (0) 0 (0) 1 (4.7) 2 (6.9) -
Total 23 27 21 29  
melatonin concentration which is regulated by the pineal gland. 
The pineal gland influences diurnal light-dark cycle in normal 
human.
Medhat [11], Karamifar et al. [12], and Yadav et al. [13] had also 
documented hypocalcemia in neonates undergoing phototherapy. 
Karamifar et al. also noticed that none of hypocalcemic neonate 
became clinically symptomatic and the serum calcium level was in 
normal range 24 h after discontinuation of phototherapy. Hooman 
et al. [14], in 2005, concluded that phototherapy may be the risk 
factor of hypercalciuria in neonates, more for preterm newborns, 
but like our study, they could not show any correlation between 
hypercalciuria and serum calcium levels and proposed further 
research is necessary to reveal the underlying pathomechanism. 
Zarkesh et al. [15] also showed a statistically significant difference 
in urinary calcium/creatinine ratio (mg/mg) at commencement 
and after 48 h of phototherapy in enteric term newborn. They also 
recommended further investigation for clarifying the importance 
of this phenomenon.
CONCLUSION
The current study showed the existence of the hypocalcemia 
in newborns undergoing phototherapy, both in preterm and 
term newborns. However, its clinical relevance in the form of 
symptomatology and underlying pathomechanism like increased 
urinary calcium excretion needs to be studied in studies with 
larger sample size.
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